Keyphrases
Taiwan
100%
Confidence Interval
61%
National Cohort Study
48%
Population-based Cohort Study
36%
Adjusted Hazard Ratio
29%
Acute Myocardial Infarction
26%
Nested Case-control Study
19%
Cervical Cancer Prevention
17%
Population-based Study
17%
Breast Cancer Prevention
16%
ST-elevation Myocardial Infarction (STEMI)
15%
Drug-eluting Stent
15%
Georgia
15%
Parkinson's Disease
15%
Low Risk
14%
Percutaneous Coronary Intervention
14%
End-stage Renal Disease
14%
Hospitalization
13%
National Health Insurance Research Database (NHIRD)
13%
Medicaid
13%
High Risk
12%
Ischemic Stroke
12%
Patients with Diabetes
12%
Risk Factors
12%
Drug-eluting Stent Implantation
12%
Newly Diagnosed
11%
Chronic Obstructive Pulmonary Disease
10%
Treatment Patterns
10%
Taiwan National Health Insurance Research Database
10%
Anemia
10%
Metformin
10%
All-cause Mortality
10%
Incidence Rate
9%
Total Hip Replacement
9%
Post-stroke Epilepsy
9%
Dry Eye
9%
Epidemiology
9%
Aspirin
9%
Dementia Risk
9%
Kidney Disease Progression
9%
Comorbidity
8%
Myocardial Infarction
8%
Clinical Outcomes
8%
Subdistribution Hazard Ratio
8%
Population-based
8%
Cervical Cancer
8%
Type 2 Diabetes Mellitus (T2DM)
8%
Type 1 Diabetes Mellitus (T1DM)
8%
Adjusted Odds Ratio
7%
Taiwanese
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
57%
Acute Heart Infarction
26%
Cerebrovascular Accident
22%
Case-Control Study
16%
Non Insulin Dependent Diabetes Mellitus
16%
Diseases
13%
End Stage Renal Disease
13%
Comorbidity
13%
Breast Cancer
13%
Chronic Obstructive Lung Disease
13%
Uterine Cervix Cancer
13%
Brain Ischemia
12%
Congestive Heart Failure
11%
Heart Infarction
11%
Antiplatelet
10%
Metformin
10%
Atrial Fibrillation
10%
Parkinson's Disease
10%
Acetylsalicylic Acid
10%
Hemodialysis
9%
Eye Disease
9%
Dry Eye
9%
Bleeding
9%
Diabetes Mellitus
8%
Non ST Segment Elevation Myocardial Infarction
8%
Kidney Disease
7%
ST Segment Elevation Myocardial Infarction
7%
Sodium Valproate
7%
Clopidogrel
6%
Phenytoin
6%
Gastroesophageal Reflux
6%
Glaucoma
6%
Alzheimer's Disease
6%
Acute Myeloid Leukemia
6%
Anticonvulsive Agent
6%
Warfarin
6%
Rivaroxaban
6%
Statin (Protein)
6%
New-Onset Atrial Fibrillation
6%
Cardiogenic Shock
6%
Cardiovascular Disease
6%
Respiratory Failure
6%
Survival Rate
5%
All Cause Mortality
5%
Chemotherapy
5%
Cancer Registry
5%
Medicine and Dentistry
Cohort Analysis
37%
Hazard Ratio
29%
Cancer Therapy
19%
Cervical Cancer Prevention
16%
Breast Cancer Prevention
16%
Drug-Eluting Stent
16%
Apoplexy
16%
Acute Heart Infarction
12%
Breast Cancer
11%
Comorbidity
11%
Brain Ischemia
10%
Diseases
10%
Parkinson's Disease
10%
Case-Control Study
10%
Cervical Cancer
9%
Chronic Obstructive Pulmonary Disease
9%
Anemia
9%
Cohort Effect
9%
Congestive Heart Failure
9%
End Stage Renal Disease
8%
Medicaid
7%
Reoperation
7%
Proportional Hazards Model
7%
Cancer Registry
6%
New-Onset Atrial Fibrillation
6%
Nephropathy
6%
Survival Rate
6%
Percutaneous Coronary Intervention
6%
Hip Replacement
6%
Percutaneous Vertebroplasty
6%
Acute Myeloid Leukemia
6%
Alzheimer's Disease
6%
Compression Fracture
6%
Surgeon
6%
Dry Eye
6%
Eye Disease
6%
Proton-Pump Inhibitor
6%
Hemodialysis
6%
Cardiogenic Shock
6%
Womens Health
6%
Autism
6%
Overall Survival
6%
Retrospective Cohort Study
5%
Diabetes Mellitus
5%
ST Segment Elevation Myocardial Infarction
5%
Respiratory Failure
5%
Charlson Comorbidity Index
5%
Combination Therapy
5%
Antiplatelet
5%
